Hosted on MSN6d
FDA approves 'ketamine' nasal spray for depression — here's everything you need to know
A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with ...
BioPharma Dive3d
Shares of psychedelics biotech nearly double on depression data
The small, Ireland-based company GH Research said its inhaled version of mebufotenin — a molecular cousin to psilocybin — was ...
How Eagles’ DeVonta Smith rescued his trainer from depression: ‘I had to change my narrative’
Green, who was coming off a year-long suspension in 2010 after testing positive for marijuana, tested positive for marijuana ...
News on 64d
FDA expands approval for antidepressant nasal spray
The Food and Drug Administration recently expanded approval for Spravato, an antidepressant nasal spray used to treat ...
FierceBiotech4d
Irish biotech's inhaled drug reduces depression in phase 2 trial
The inhaled mebufotenin candidate, dubbed GH001, was evaluated in the midstage study of 81 patients with treatment-resistant depression. The 40 patients who received GH001 saw an average 15.2 point ...
Surviving an overdose can be excruciating. New research suggests it doesn’t have to be
Naloxone is a fantastic tool in reducing opioid deaths, but gentler versions would be helpful for fighting overdose ...
BioSpace4d
GH’s Inhaled Psychedelic Succeeds in Mid-Stage Depression Trial
In a Phase IIb trial, GH001 elicited significant drops in treatment-resistant depression. The news comes less than two weeks ...
How Eagles’ DeVonta Smith rescued his trainer: ‘I had to change my narrative’
Green, who was coming off a year-long suspension in 2010 after testing positive for marijuana, tested positive for marijuana ...
Lipocine plans phase 3 study for postpartum depression drug
SALT LAKE CITY - Lipocine Inc. (NASDAQ: NASDAQ:LPCN), a biopharmaceutical company with a market capitalization of approximately $24 million, announced today that it will conduct a phase 3 safety and ...
STAT2h
Lilly expands GLP-1 research to hypertension, neuro conditions
Today, we have a look at the White House's reported plans to make major cuts across federal health agencies. Also, Eli Lilly is expanding the ...
Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, to Present February 10th at BIO CEO & Investor Conference
Magdalena aiming to submit Investigational New Drug (IND) application in 2025 to the FDA for a next-generation psychoactive prescription drug candidate for potential mental health indications such as ...
studyfinds4d
Nutrient that makes tomatoes red might rewire depressed brains
Discover the potential of lycopene in alleviating depression. Learn how the compound found in tomatoes improves brain cell ...